GlassScriptPhysician profile
Rabia Bajwa
NPI 1699730465
$2,276.82
in general payments reported to CMS, 2019-2025
18 companies · $499 in 2025
The $499 reported for 2025 was more than what 79% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $562 · 2020: $225 · 2021: $62.36 · 2022: $73.42 · 2023: $391 · 2024: $464 · 2025: $499.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $960 · Education: $244 · Consulting Fee: $150.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $960.29 |
| Education | $243.93 |
| Consulting Fee | $150.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Jazz Pharmaceuticals INC. | $521.98 | 2020-2025 | Xywav |
| Axsome Therapeutics, INC. | $404.45 | 2023-2025 | Sunosi |
| Harmony Biosciences LLC | $301.05 | 2020-2025 | Wakix |
| Glaxosmithkline, LLC. | $262.57 | 2019-2023 | Nucala |
| Resmed Corp | $176.71 | 2019-2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $113.79 | 2019-2020 | |
| Astrazeneca Pharmaceuticals LP | $88.21 | 2019-2021 | |
| Genzyme Corporation | $80.80 | 2019 | |
| Regeneron Healthcare Solutions, INC. | $75.57 | 2019-2020 | |
| Philips North America LLC | $61.44 | 2020-2023 | |
| Actelion Pharmaceuticals US, INC. | $46.98 | 2019-2020 | |
| Novartis Pharmaceuticals Corporation | $27.80 | 2019 | |
| Merck Sharp & Dohme LLC | $25.16 | 2019 | |
| Inspire Medical Systems, INC. | $22.78 | 2023 | Inspire |
| Grifols USA, LLC | $22.66 | 2019 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $18.53 | 2025 | Zepbound |
| Circassia INC. | $14.13 | 2019 | |
| Cumberland Pharmaceuticals, INC. | $12.21 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Rabia Bajwa listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.